Investigator CV - clinicalmethods.com

advertisement
CURRICULUM VITAE
Reid J. Robison, MD, MBA
POSITION TITLE:
Director of Clinical Research
OFFICE ADDRESS:
Clinical Methods LLC
676 E. Vine St. #5
Salt Lake City, Utah, United States
PROFESSIONAL LICENSURE:
SPECIALIZATION:
CONTACT INFORMATION:
Telephone: 801-290-5320
Fax: 801-290-5321
e-Mail: reid@clinicalmethods.com
Utah, State License- Physician (MD), #370399-1205
Utah, Controlled Substance-Physician (MD), #370399-8905
Utah, DEA Certificate- Physician (MD), #FR0068052
Idaho, State License- Physician (MD), 10016 exp. 6/30/12
Psychiatrist
EDUCATION/TRAINING:
DEGREE
INSTITUTION AND LOCATION
(if applicable)
YEAR(s)
FIELD OF STUDY
University of Utah School of Medicine
Salt Lake City, Utah
Postdoctoral
Fellow
2009-2010 Biomedical informatics
NLM training grant
University of Utah School of Medicine (Center
for Clinical & Translation Science)
Salt Lake City, Utah
Research
Fellow
2008-2009 Clinical Investigation
University of Utah Department of Psychiatry
Salt Lake City, Utah
Co-Chief
Resident
2007-2009 Psychiatry
University of Utah School of Medicine
Salt Lake City, Utah
Resident
University of Utah School of Medicine
Salt Lake City, Utah
Intern
Univeristy of Utah, Salt Lake City, Utah
M.B.A
University of Utah School of Medicine
Salt Lake City, Utah
M.D.
Brigham Young University
Provo, Utah
B.S.
Updated 21 Sept 2011
Initials___________________
2006-2009 Psychiatry
2005-2006 Psychiatry
2001-2005 Business Administration
2001-2005 Medicine
1994-2001 Neuroscience
Page 1 of 9
POSITIONS AND EMPLOYMENT:
2011 – Present
Partner and Director of Clinical Research, Clinical Methods LLC, Salt Lake City, UT
2011 - Present
Medical Director, Consultation-Liaison Psychiatry, Intermountain Medical Center, Murray,
UT
2007 – 2010
Consulting Psychiatrist, Discovery Academy Residential Adolescent Treatment Center,
Provo, UT
2010 - Present
Consulting Psychiatrist, Utah Health & Human Rights Project (Refugees & torture
survivors), Salt Lake City, UT
2009 - 2011
Clinical Instructor, University of Utah Department of Psychiatry, Salt Lake City, UT
2009 – 2011
Associate Director, University of Utah Healthcare Psychiatry Research Clinic, Clinical
Trials Salt Lake City, UT
2007 - 2009
Consulting Psychiatrist (Youth Sex Offenders), Pinecreek Ranch, Ascent Inc.
Springville, UT
2007 - 2009
Consulting Psychiatrist (Youth Substance Abuse), Ascent Country Residential, Ascent
Inc., Springville, UT
2007 - 2009
Consulting Psychiatrist (Youth Sex Offenders), Oxbow Academy, (Telepsychiatry)
Wales, UT
2006 - 2007
Outpatient Psychiatrist, Comprehensive Psychological Services, Salt Lake City, UT
2006 - 2007
Physician Associate, University of Utah Neuropsychiatric Institute, Salt Lake City, UT
06/01/2010
American Board of Psychiatry & Neurology (Psychiatry), Board Certified
OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS:
2009 - Present
2008 - Present
2008 - Present
2008 - 2009
2005 - Present
2005 - Present
2010 - Present
2010 - Present
2008 - 2009
2007 - 2008
2003 - 2004
2006 – Present
Updated 21 Sept 2011
Member, American Society of Clinical Psychopharmacology
Member, Public Population Project in Genomics
Member, International Genetic Epidemiology Society
Member, American Society of Human Genetics
Member, Utah Psychiatric Association
Member, American Psychiatric Association
State Refugee Health Committee Member, Utah State Government, Salt Lake City,
UT
Utah Refugee Conference, Organizing Committee Member
Resident Board Representative, Utah Psychiatric Association, Salt Lake City, UT
Co-Chief Resident, University of Utah Department of Psychiatry, Salt Lake City,
UT Vice-Chair, AMA-MSS Region I, Salt Lake City, UT
Utah Medical Association
Initials___________________
Page 2 of 9
OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS:
ADMINISTRATION
2010 – Present
2011 – Present
2009 – Present
Editorial / Journal
2010 – Present
2009 – Present
Medical Director, Free Mental Health Clinic, Polizzi Foundation, Salt Lake City,
UT
Medical Director, Consultation-Liasion Psychiatry, Intermountain Medical Center,
Murray, UT
Associate Director, University of Utah Healthcare Psycgiatry Research Clinic, Salt
Lake City, UT
Ad Hoc Review, Neuropsychopharmacology
Ad Hoc Review, ADHD Attention Deficit Hyperactivity Disorder Journal/
HONORS:
2009 - 2010
2009 - 2010
2008 – 2010
2007 - 2008
2007 – 2008
2004 – 2005
2001 - 2002
1999 - 2001
Career Development Institute in Psychiatry (Standford University)
Resident Research Award (University of Utah Department of Psychiatry)
Chief Resident Service Award (University of Utah Department of Psychiatry)
APIRE/Janssen Research Scholars Award (APA/APIRE)
Outstanding Resident Award (University of Utah Department of Psychiatry)
Outstanding Poster Award (Society for Computer Applications in Radiology)
University Honors (Brigham Young University)
Dean's List, College of Biology (Brigham Young University)
RESEARCH EXPERIENCE:
Year
2009-2011
Indication
Major Depressive
Disorder
Role
Sub-I
2009 - 2011
Major Depressive
Disorder
Sub-I
2009 - 2011
Bipolar I Disorder
Sub-I
2009 - 2011
Major Depressive
Disorder
Sub-I
2010 - 2011
Major Depressive
Disorder (MDD)
Principal
Investigator
Updated 21 Sept 2011
Research Project
A Phase 2, Multicenter, Randomized, Doubl-blind,
Placebo-Controlled Study of the Safety and
Efficacy of OPC-34712 as Adjunctive Therapy in
the Treatment of Patients with Major Depressive
Disorder
A Multicenter, Long-term, Open-Label Study to
Assess the Safety and Tolerability of OPC-34712 as
Adjunctive Therapy in the Treatment of Outpatients
with Major Depressive Disorder
Study to Assess the Safety and Efficacy of
Olanzapine and Fluoxetine Combination versus
Placebo in Patients Ages 10-17 in the Treatment of
Major Depressive Episodes Associated with Bipolar
I Disorder
A Phase 2, Multicenter, Open-Label Study to
asssess Safey & Tolerability of OPC-34712 as
Adjunctive Therapy in the Treatment of Patients
with Major Depressive Disorder
An 8-week, randomized, double-blind, placebocontrolled, parallel-group,
multi-center study
of the efficacy and safety of agomelatine 0.5 mg
and 1 mg sublingual tablets administered once daily
Initials___________________
Page 3 of 9
2009 - 2011
Bipolar I Disorder
Sub-I
2005 - 2011
Major Depressive
Disorder
Sub-I
2008 - 2011
Bipolar I
Depression
Sub-I
2009 - 2011
Major Depressive
Disorder
Sub-I
2008 - 2010
Bipolar I Disorder
Sub-I
2008 - 2010
Generalized
Anxiety Disorder
Sub-I
Bipolar I
Depression
Sub-I
2008 - 2010
2008 - 2010
Adult ADHD
2009 - 2010
Major Depressive
Disorder
Sub-I
2006 - 2010
Major Depressive
Disorder
Sub-I
2006 - 2010
Stuttering
Sub-I
Updated 21 Sept 2011
Principal
Investigator
in patients with Major Depressive Disorder (MDD)
Study to Assess the Safety and Efficacy of
Olanzapine and Fluoxetine Combination Versus
Placebo in Patients Ages 10 to 17 in the Treatment
of Major Depressive Episodes Associated with
Bipolar I Disorder
A Long-term, Observational, Multi-center patient
Outcome Registry to Collect Data in Patients with
Treatment-Resistant Depression
A Phase II Randomized, Double-Blind, PlaceboControlled, Flexible-Dose
Study to Assess the
Safety, Tolerability and Efficacy of RG2417
(Uridine) in the Treatment of Bipolar I Depression
A Phase 2, Multicenter, Open-Label Study to
asssess Safey & Tolerability of OPC-34712 as
Adjunctive Therapy in the Treatment of Patients
with Major Depressive Disorder
SCA102833: The Evaluation of LAMICTAL as an
Add-on Treatment for Bipolar I Disorder in
Children and Adolescents, 10 to 17 years of age
A Phase 3, Randomized, Double-blind, Parallel
Group, 10-week Placebo
Controlled Fixed
Dose Study of PD 0332334 and Paroxetine
Evaluating the Efficacy and Safety of PD 0332334
for the Treatment of Generalized Anxiety Disorder
A Phase II Randomized, Double-blind, Placebo
Controlled, Flexiable Dose Study to Assess the
Safety, Tolerability and Efficacy of RG2417
(Uridine) in the Treatment of Bipolar I Depression
A Candidate Gene Case-Control Study of Adult
ADHD
A Phase 2, Multicenter, Randomized, Double-blind,
Placebo-controlled Study of the Safey & Efficacy
of OPC-34712 as Adjunctive Therapy in the
Treatment of Patients with Major Depressive
Disorder
Randomized Comparison of Outcomes in Patients
withTreatment-Resistant Depression who Receive
VNS Therapy Administered at Different Amounts
of Electrical Charge
An 8-week, Double-Blind, Randomized,
Multicenter, Flexible-Dose, Placebo Controlled
Pilot Study of Pagoclone in Patients with Persistent
Developmental Stuttering Followed by a 52-Week
Open-Label Extension
Initials___________________
Page 4 of 9
2005 - 2010
Major Depressive
Disorder
Sub-I
A Long-term, Observational, Multi-center patient
Outcome Registry to Collect Data in Patients with
Treatment-Resistant Depression
2008 - 2009
Generalized
Anxiety Disorder
Sub-I
A 52-week Open Label Safety Study of PD
0332334 in Subjects with Generalized Anxiety
Disorder
2006 - 2009
Adult ADHD
2008 - 2009
Major Depressive
Disorder
2007 - 2008
Adult ADHD
Sub-I
A study to evaluate the efficacy and safety of PF03654746 in adults with ADHD
2007 - 2008
Generalized
Anxiety Disorder
Sub-I
2006 - 2008
Bipolar I
Sub-I
2006 - 2008
Major Depressive
Disorder
Sub-I
2006 - 2008
Major Depressive
Disorder
Sub-I
2007 - 2008
Genotyping
CoInvestigator
A Multicenter, Randomized, Double-Blind, Placebo
and Escitalopram Controlled Trial of the Safety and
Efficacy of Pexacerfont (BMS-562086) in the
Treatment of Outpatients with Generalized Anxiety
Disorder (CN148-015)
Efficacy of Aripiprazole in Combination with
Lithium or Valproate in the Long Term Treatment
of Mania in Patients with Bipolar I Disorder
Partially Nonresponsive to Lithium or Valproate
Monotherapy (CN138-189)
A Multi-Centered, Randomized, Double-Blind,
Placebo Controlled Study
of the Safety and
Efficacy of Aripiprazole as adjunctive Therapy in
the Treatment of Patients with Major Depressive
Disorder
A Multicenter, Randomized, Double-Blind, Placebo
and Escitalopram Controlled Trial of the Safety and
Efficacy of BMS-562086 in the Treatment of
Outpatients with Major Depressive Disorder (CN
148-007-017)
Autism Gene Discovery
2007 - 2008
Adult ADHD
Principal
Investigator
2006 - 2007
Opiate
Detoxification
Sub-I
Updated 21 Sept 2011
CoPrincipal
Investigator
Sub-I
Methylphenidate Transdermal System (MTS) in the
Treatment in Adult ADHD
Randomized, double-blind, placebo- controlled
study of Vilazadone Pgx efficacy, safety
andbiomarkers of response in major depression
disorder
Pharmacogenetics of Adult ADHD in Clinical
Trials Seed Grant
A Phase III, Randomized, Multi-Center, Double
Blind, Placebo-Controlled Study of Safety and
Efficacy of Lofexidine for Relief of Symptoms in
Subjects Undergoing Inpatient Opiate
Initials___________________
Page 5 of 9
Detoxification
Adult ADHD
Sub-I
2004 - 2007
2002 - 2004
Community Health
CoPrincipal
Investigator
2003 - 2004
Biomedical
Informatics
Principal
Investigator
A Randomized, Double-Blind Comparison of
Placebo and Atomoxetine
Hydrochloride
Given Once a Day in Adults with AttentionDeficit/Hyperactivity Disorder: with a Secondary
Examination of Impact of Treatment on Family
Functioning (B4Z-US-LYCW)
The Utah Rural Outreach Program Pfizer/AAMC
Caring for Communities Grant, Association of
American Medical Colleges
Development of an Informatics Tool for Vendorneutral Collection of Radiological Images for
Educational Use
PUBLICATIONS:
06/22/2011
Using VAAST to Identify an X-Linked Disorder Resulting in Lethality in Male
Infants Due to N-Terminal Acetyltransferase Deficiency.
Am J Hum Genet, Rope,
A. F., Wang, K., Evjenth, R., Xing, J., Johnston, J. J., Swensen, J. J., Johnson, W. E.,
Moore, B., Huff, C. D., Bird, L. M., Carey, J. C., Opitz, J. M., Stevens, C. A., Jiang,
T., Schank, C., Fain, H. D., Robison, R., Dalley, B., Chin, S., South, S
05/01/2011
Methylphenidate transdermal system in adult ADHD and impact on emotional and
oppositional symptoms.
J Atten Disord, Marchant, B.K., Reimherr, F.W.,
Robison, R.J., Olsen, J.L., Kondo, D.G.
Long-term open-label response to atomoxetine in adult ADHD: influence of sex,
emotional dysregulation, and double-blind response to atomoxetine., 2011.
Marchant, B., Reimherr, F., Halls, C., Williams, E., Strong, R., Kondo, D., Soni, P.,
Robison, R.
Genome-wide linkage using the Social Responsiveness Scale in Utah autism
pedigrees.
Mol Autism, Coon, H., Villalobos, M. E., Robison, R. J., Camp, N. J.,
Cannon, D. S., Allen-Brady, K., Miller, J. S., McMahon, W. M.
Genome-wide linkage analyses of two repetitive behavior phenotypes in Utah
pedigrees with autism spectrum disorders.
Mol Autism, 2010.
Cannon, D. S.,
Miller, J. S., Robison, R. J., Villalobos, M. E., Wahmhoff, N. K., Allen-Brady, K.,
McMahon, W. M., Coon, H.
Personality disorders in ADHD Part 2: The effect of symptoms of personality
disorder on response to treatment with OROS methylphenidate in adults with
ADHD.
Ann Clin Psychiatry.
Personality disorder in ADHD Part 1: Assessment of personality disorder in adult
ADHD using data from a clinical trial of OROS methylphenidate.
Ann Clin
Psychiatry.
Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity
disorder: a retrospective data analysis.
J Clin Psychiatry
Page 6 of 9
Informatics in Initials___________________
radiology (infoRAD): Vendor-neutral case input into a server-based
03/07/2011
2010
2010
05/01/2010
05/01/2010
02/01/2008
Updated11/01/2006
21 Sept 2011
01/03/2003
digital teaching file system.
Radiographics. Kamauu, A.C., DuVall, S.L.,
Robison, R.J., Liimatta, A.P., Wiggins, R.H., Avrin, D.E.
Effect of central angiotensin II on body weight gain in young rats.
Brain Res.
Porter, J. P., Anderson, J. M., Robison, R. J., Phillips, A. C.
PUBLISHED ABSTRACTS & POSTER PRESENTATIONS:
2010
2009
2009
2009
2009
2009
2009
2009
2009
2009
2008
Updated 21 Sept 2011
Allen-Brady K, Cannon D, Robison R, McMahon WM, Coon H. A unified theory
of autism revisited: linkage evidence points to chromosome X using a high-risk
subset of AGRE families [Abstract].Autism Res.
Keeshin B, Robison R, Pratt A, Sheetz J. Past Childhood Abuse Among Homeless
Youth: Prevalence, Perceived Ongoing Effect and Interest In Treatment
[Abstract].American Academy of Child and Adolescent Psychiatry.
Williams ED, Kondo D, Reimherr FW, Marchant BK, Halls C, Strong RE,
Christopherson DC, Robison RJ, Olsen JL. Oppositional Defiant Disorder
Symptoms In An Adult ADHD Trial of Methylphenidate Transdermal System
(MTS) [Abstract].American Academy of Child and Adolescent Psychiatry.
Robison RJ, Matsunami N, Allen-Brady K, Cannon D, Miller J, Hobbs M,
Stevens J, Baird L, Varvil T, Pingree C, Leppert MF, McMahon W, Coon H.
Inheritance of 15q11-13 Duplications in Autism Pedigrees [Abstract].American
Society of Human Genetics.
Coon H, Villalobos M, Robison R, Cannon D, Allen-Brady K, Leppert MF, Miller
J, McMahon WM. Genome-wide linkage using the Social Reciprocity Scale
(SRS) in Utah autism pedigrees [Abstract].American Society of Human Genetics.
Cannon D, McMahon, Allen-Brady K, Miller J, Robison R, Coon H.
Chromosome 15 linkage analysis of two repetitive behavior phenotypes in Utah
pedigrees with autism spectrum disorders [Abstract].American Society of Human
Genetics.
Allen-Brady K, Cannon C, Robison R, McMahon W, Coon H. A Unified Theory
of Autism Revisited: Linkage Evidence Points to the IL1RAPL1 Gene using a
High-Risk Subset of AGRE Families [Abstract].American Society of Human
Genetics.
Reimherr FW, Marchant B, Williams E, Strong RE, Halls C, Soni P, Robison RJ.
Methyphenidate Transdermal System in the Treatment of Adults with ADHD: A
Preliminary Report [Abstract].American Psychiatric Association.
Robison RJ, Farley MA, Cannon D, Allen-Brady K, Matsunami N, Stevens J,
Baird L, Pingree C, Leppert MF, McMahon W, Coon H. Initial Evaluation of
Copy Number Variation in a Follow-up of Adults with Autistic Spectrum
Disorders: a Behavioral Phenotype-Genotype Study [Abstract].APA Junior
Investigator Research Colloquium.
Reimherr FW, Marchant BK, Wender P, Roessler M, Robison RJ. Emotional
Dysregulation and Oppositional Defiant Disorder in a Clinical Trial of
Methyphenidate Transdermal System in the Treatment of Adults with ADHD
[Abstract].2nd International Congress on ADHD.
Allen-Brady K, Matsunami N, Stevens J, Baird L, Robison R, Cannon D, Miller J,
Leppert T, Pingree C, Leppert MF, McMahon W, Coon H. Follow-up of Five
Linkage Peaks For Autism in Extended Utah Kindreds [Abstract].American
Society of Human Genetics.
Initials___________________
Page 7 of 9
2008
Gale P, Reimherr F, Marchant B, Robison R, Williams E, Strong R, Halls C, Soni
P. The Effect of Symptoms of Personality Disorder on in Adult ADHD
[Abstract].Biological Psychiatry.
2008
Robison R, Reimherr F, Marchant B, Gale P, Williams E, Strong R, Halls C, Soni
P. Assessing Personality Disorder in Adults with ADHD, and Its Effects on
Response to Treatment with OROS Methylphenidate (OROS MPH)
[Abstract].NCDEU.
Robison R, Reimherr F, Faraone S, Marchant B, Adler L, Strong, Soni P. Gender
Differences in ADHD Adults During Clinical Trials with Atomoxetine
[Abstract].American Psychiatric Association.
Blanch R, Robison R, Avrin D, Wiggins R, Liimatta A. Synchronized Digital
Teaching Files on a PDA: an Educational Tool [Abstract].Society for Computer
Applications in Radiology.
2005
2004
ORAL PRESENTATIONS:
Meeting
Presentations
2011
2011
2010
2009
2009
2009
2009
2006
2003
2003
2003
Grand Rounds
Presentations
2010
2010
2009
Updated 21 Sept 2011
Reimherr F, Marchant B, Olsen J, Wender P, Robison R. Oppositional
Defiant Disorder in Adults with ADHD. In-Press
Medications after Traumatic Brain Injury, University of Utah Healthcare
Genetics of Suicidal Behaviors- Generations Conference
Genetics of Suicide. Oral Platform Presentation, Career Development
Institute for Psychiatry, Stanford University, Palo Alto, CA, USA
Initial Evaluation of Copy Number Variation in a Follow-up of Adults with
Autism Spectrum Disorders: a Behavioral Phenotype-Genotype Study.
American Psychiatric Institute Junior Investigator Research Colloquium,
San Francisco, CA, USA
Whole exome sequencing in Autism pedigrees- University of Utah,
Department of Biomedical Informatics, Translational Research in Progress
Personalized medicine in a digital age- University of Utah, Department of
Biomedical Informatics, Clinical Informatics Course
Enhancing Employee Satisfaction, Communication and Productivity in the
Workplace. Hunter Douglas, Inc. West Valley City, UT
Vendor-neutral Case Input to a Server-based Digital Teaching File
System. Radiological Society of North American, Scientific Session
Server-based Digital Teaching File Database Synchronization with a PDA.
Radiological Society of North America, Radiology Informatics Session.
Improving the Shortage of Rural Physicians by Targeting High School and
Medical Students. Rural Emergency Medicine Summit, Albuquerque, NM,
USA
"Neuropsychiatric Genetics: The Search for Genes Underlying Autism
Spectrum Disorder." Brigham Young University Neuroscience Center
"Psychiatric Genetics, Bioinformatics, and the Future of Personalized
Psychiatry" University of Utah, Department of Psychiatry
Copy Number Variation in Psychiatric Disorders. University of Utah,
Initials___________________
Page 8 of 9
Department of Psychiatry, Salt Lake City, UT, USA
Updated 21 Sept 2011
Initials___________________
Page 9 of 9
Download